NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

Ads

You May Also Like

Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs

CHAPEL HILL, N.C., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

MDxHealth (R): MDxHealth Reports Half Year 2018 Results

NEWS RELEASE    REGULATED INFORMATION  INTERIM FINANCIAL REPORT                ...

Delcath Announces First Quarter 2018 Financial Results

NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional ...